XGN
XGN
NASDAQ · Biotechnology

Exagen Inc

$3.51
+0.15 (+4.46%)
As of Feb 8, 2:09 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 19.00M 17.09M 20.29M
Net Income -5,617,065 -4,142,594 -5,000,058
EPS
Profit Margin -29.6% -24.3% -24.7%
Rev Growth -4.6% +9.1% +5.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 36.91M 33.95M 31.55M
Total Equity 110.05M 108.93M 108.86M
D/E Ratio 0.34 0.31 0.29
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -7,619,084 -7,262,848 -9,094,907
Free Cash Flow -5,290,454 -5,494,601 -5,886,545